In Re RenovaCare, Inc. Securities Litigation
Case Number:
2:21-cv-13766
Court:
Nature of Suit:
Judge:
Firms
- Calcagni & Kanefsky
- Carella Byrne
- Cozen O'Connor
- Dilworth Paxson
- Duane Morris
- King & Spalding
- Lite DePalma
- Lowenstein Sandler
- Lowey Dannenberg
- Pomerantz LLP
- WilmerHale
Companies
Sectors & Industries:
-
September 24, 2024
Biotech RenovaCare Investors Seek OK Of $2M Deal
Biotechnology company RenovaCare Inc. has reached a $2 million deal to end a consolidated proposed class action alleging it pumped its stock prices by using a secret paid promotional campaign, the company's investors have told a New Jersey federal judge.
-
June 04, 2024
Biotech RenovaCare Can't Beat Investors' Stock Promo Suit
A New Jersey federal judge has ruled that investors in biotechnology company RenovaCare Inc. failed to prove their case against firms they accused of profiting from a scheme to pump up the company's shares, but otherwise allowed their claims to proceed against the maker of skin burn treatments and a few of its executives.
-
September 15, 2021
4 Firms Seek To Lead Biotech Stock Promotion Scheme Suit
Pomerantz LLP, Hagens Berman Sobol Shapiro LLP, The Rosen Law Firm PA and Glancy Prongay & Murray LLP have launched competing bids to steer investors' two proposed class actions against biotechnology company RenovaCare Inc. in New Jersey federal court over claims the business unlawfully engaged in a stock promotion scheme.